Prevalence of Cognitive Impairment in Patients Receiving 5- Fu Containing Chemotherapy- a Systematic Review and Meta-analysis-Reference-Cited by-同舟云学术

Prevalence of Cognitive Impairment in Patients Receiving 5- Fu Containing Chemotherapy- a Systematic Review and Meta-analysis

Published:2023-11-01 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Dsouza Anita¹,Chaudhari Jyoti¹,Ostwal Vikas²,Pawar Akash²,Saklani-Professor Avnish²,Rane Pallavi³,Jagdish Prathepa²

Affiliation:

1. Mahatma Gandhi Institute of Medical Sciences

2. Tata Memorial Hospital

3. Advanced Centre for Treatment, Research and Education in Cancer

Abstract

Abstract Introduction- The burden of cognitive impairment in patients who receive chemotherapy is significant. This review seeks to find out the prevalence of cognitive impairment in patients who have received 5 FU containing chemotherapy Methods- Pubmed, sciencedirect, CINAHL and Wiley were searched using the following key words in combination (cognition OR cognitive function OR cognitive impairment OR cognitive dysfunction) AND (5 FU OR 5 Fluorouracil OR chemotherapy). The reference lists of relevant studies were hand-searched to identify additional studies by two reviewers Results- The overall prevalence of cognitive in patients who received 5 FU containing chemotherapy is 29%. Discussion- Further research should study the impact of various chemotherapy protocols on cognitive functions in cancer survivors

Publisher

Research Square Platform LLC

Reference31 articles.

1. progress in cancer survival, mortality, and incidence in seven high- income countries 1995–2014, (ICBP SURVMARK-2):a population –based study;Arnol M;Lancet Oncol,2019

2. https://gco.iarc.fr/ WHO. : Global Cancer Observatory, International Agency for Research on Cancer.

3. Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer Survivorship questionnaires;Leeuwen M;Health Qual Life Outcomes,2018

4. Chemotherapy cancer treatment during the past sixty years;Furue H;Gan To Kagaku Ryoho

5. Effect of chemotherapy on Overall Survial in Contemporary metastatic prostate Cancer patients;Hoeh B;Front Oncol,2021